Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Altschuller currently holds 142,500 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Altschuller has been a net seller of CERE stock. They have purchased $32.1K and sold $571.9K worth of shares.
Susan Altschuller's most recent insider trade was on Jan 6, 2026, when they sold 142,500 shares at $0.00 per share.
Susan Altschuller serves as Executive at Cerevel Therapeutics Holdings, Inc. (CERE). They have executed 10 insider transactions totaling $604.0K over their tenure at the company.
Susan Altschuller holds the position of Executive at Cerevel Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Susan Altschuller has shown a selling trading pattern, with $32.1K in total purchases and $571.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Altschuller was on Dec 20, 2023, when they sold $571.9K worth of CERE shares. This transaction involved 13,808 shares at $41.42 per share.
Susan Altschuller currently owns 142,500 shares of Cerevel Therapeutics Holdings, Inc. (CERE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Altschuller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Altschuller has 10 Form 4 filings on record as an insider at Cerevel Therapeutics Holdings, Inc..
Set alerts for Susan Altschuller and 40,000+ other insiders.